There is epidemiological evidence for environmental factors in ankylosing spondylitis (AS),' and the clinical overlap between AS and reactive arthritis suggests an infectious agent. Increases in the serum IgA concentration2 implicate a mucosal site, and additional circumstantial evidence includes increased bowel permeability3 and subclinical distal ileitis4 in a proportion of patients with AS.
Ebringer's group reported an immunological cross reaction between HLA-B27 and Klebsiella pneumoniae,5 with increased antibodies to klebsiella6 and faecal carriage of klebsiella in patients with active AS,7 whereas Geczy investigated a klebsiella product ('modifying factor') which specifically interacts with B27.8 Unfortunately, others have had difficulty repeating these observations,9-2 and an alternative approach to studying the involvement of klebsiella antigens in AS seems appropriate.
Although the classical clinical manifestations of immune complex disease are In this study immune complexes were measured in serum samples from patients with AS by two different methods and related to indices of disease activity, and immune complexes from selected subjects were probed for the presence of klebsiella antigens.
Materials and methods

CLINICAL MATERIAL
The 49 patients with AS and 23 control subjects were part of a group described previously.2' Ten patients with AS had peripheral joint synovitis. Seven were taking sulphasalazine and the remainder non-steroidal anti-inflammatory drugs, simple analgesics, or no drugs. Blood was collected into prewarmed (37°C) 20 
